Article Text
Abstract
Objective This study aimed to investigate the prevalence of glaucoma with associated factors in the rural populations of 10 provinces in China.
Design A population-based cross-sectional study.
Methods All participants aged 6 years or older from 10 provinces completed visual acuity testing, slit-lamp examination, ophthalmoscopy and non-contact tonometry. Glaucoma suspects underwent fundus photography, Goldmann applanation tonometry, visual field testing and gonioscopy. Glaucoma was determined according to the International Society of Geographical and Epidemiological Ophthalmology classification scheme. Associations of demographics and medical factors with glaucoma were assessed using multiple logistic regression models.
Results From June 2017 to October 2018, 48 398 of 52 041 participants were included in the final analyses. The age-standardised prevalence of glaucoma was 1.7% (95% CI 1.55% to 1.78%) among the participants older than 6 years, which was 2.1% (95% CI 1.93% to 2.23%) in participants aged over 40 years. The constituent ratios of glaucoma were: 44.4% primary angle-closure glaucoma (PACG), 34.7% primary open-angle glaucoma, 2.6% congenital glaucoma and 18.3% other types of glaucoma. Increasing age, smoking, cerebral stroke, type 2 diabetes, higher education (college or more) and higher personal income were significant risk factors for PACG. The unilateral and bilateral blindness rates in the entire study population were 4.692% and 1.068%, respectively. A family history of glaucoma was a significant risk factor for the prevalence of glaucoma and blindness in at least one eye.
Conclusions Rural populations have a high prevalence of glaucoma, which should be included in chronic disease management programmes in China for long-term care.
- Glaucoma
- Epidemiology
- Public health
Data availability statement
Data are available on reasonable request.
Statistics from Altmetric.com
Data availability statement
Data are available on reasonable request.
Footnotes
YL, BY and XC contributed equally.
Contributors HY conceived the China Rural Glaucoma Cohort Study (China-RG Study) and take responsibility for its all aspects. HY, YuL and BY designed the study. YoL, ZX, XiaC, ZY, XW, DH, XM, WG, RW, YY, SC, JZ, ZS, JW, JP, WW, MW, JG, HZ, LT, WD, XP, GL, XD, XH, XG, ZZ, ZS and CFW organise the implementation of the project. XiC, XY, XY and JiW were involved in data management and statistical analysis. YuL, BY and XiC wrote the first and subsequent drafts of the report. HY, CZ, NJT, BY and XiC were the co-principal investigators of the project, reviewed and commented on drafts of the report. HY, CZ and NJT supervised its conduct and data analysis, and provided comments on all drafts. SB, CZ and XS were the counselors. All authors interpreted data, contributed to critical revisions, and approved the final version of the Article.
Funding This research was supported by the National Natural Science Foundation of China (Grant numbers 81900883, 82020108007, 81830026), Tianjin Natural Science Foundation (Grant Number 19JCQNJC11300), Beijing-Tianjin-Hebei Special Project (Grant number, 19JCZDJC64300(Z)).
Disclaimer The sponsor or funding organisations had no role in the design or conduct of this research. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Map disclaimer The inclusion of any map (including the depiction of any boundaries therein), or of any geographic or locational reference, does not imply the expression of any opinion whatsoever on the part of BMJ concerning the legal status of any country, territory, jurisdiction or area or of its authorities. Any such expression remains solely that of the relevant source and is not endorsed by BMJ. Maps are provided without any warranty of any kind, either express or implied.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Linked Articles
- Highlights from this issue